Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Divestments (2020 - 2023)

Agilon Health's Divestments history spans 4 years, with the latest figure at $2.2 million for Q4 2023.

  • For Q4 2023, Divestments changed N/A year-over-year to $2.2 million; the TTM value through Dec 2023 reached $2.2 million, up 338.6%, while the annual FY2023 figure was $2.2 million, 338.6% up from the prior year.
  • Divestments reached $2.2 million in Q4 2023 per AGL's latest filing, up from $500000.0 in the prior quarter.
  • In the past five years, Divestments ranged from a high of $2.2 million in Q4 2023 to a low of -$3.7 million in Q1 2021.
  • Average Divestments over 4 years is $391500.0, with a median of $1.0 million recorded in 2020.
  • Peak YoY movement for Divestments: surged 30.0% in 2021, then surged 113.49% in 2022.
  • A 4-year view of Divestments shows it stood at $1.0 million in 2020, then grew by 30.0% to $1.3 million in 2021, then crashed by 61.54% to $500000.0 in 2022, then surged by 338.6% to $2.2 million in 2023.
  • Per Business Quant, the three most recent readings for AGL's Divestments are $2.2 million (Q4 2023), $500000.0 (Q1 2022), and $1.3 million (Q4 2021).